ProMIS Neurosciences Inc. (PMN) stock
PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.31+0.02 (+0.61%)
Close on Nov 16, 2026Market cap $29.68MP/E –Yield –
ProMIS Neurosciences cash
Cash and short-term investments held at the end of each period.
ProMIS Neurosciences's cash was $53.46M at Jun 30, 2026. For fiscal 2025 it was $6.15M, down 53.8% from the year before. The highest annual figure on record is $16.98M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.15M | -53.8% |
| FY2024 | Dec 31, 2024 | $13.32M | +5.5% |
| FY2023 | Dec 31, 2023 | $12.63M | +113.8% |
| FY2022 | Dec 31, 2022 | $5.91M | -65.2% |
| FY2021 | Dec 31, 2021 | $16.98M | +2004.0% |
| FY2020 | Dec 31, 2020 | $806.89K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $53.46M | +1076.8% |
| Q1 FY2026 | Mar 31, 2026 | $63.85M | +660.3% |
| Q4 FY2025 | Dec 31, 2025 | $6.15M | -53.8% |
| Q3 FY2025 | Sep 30, 2025 | $15.43M | -28.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.54M | +343.3% |
| Q1 FY2025 | Mar 31, 2025 | $8.40M | +232.0% |
| Q4 FY2024 | Dec 31, 2024 | $13.32M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $21.57M | +27.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.02M | -18.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.53M | -24.8% |
| Q4 FY2023 | Dec 31, 2023 | $12.63M | +113.8% |
| Q3 FY2023 | Sep 30, 2023 | $16.90M | +327.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.25M | -86.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.36M | -75.5% |
| Q4 FY2022 | Dec 31, 2022 | $5.91M | -65.2% |
| Q3 FY2022 | Sep 30, 2022 | $3.95M | -81.1% |
| Q2 FY2022 | Jun 30, 2022 | $8.94M | +60.3% |
| Q1 FY2022 | Mar 31, 2022 | $13.75M | +1604.6% |
| Q4 FY2021 | Dec 31, 2021 | $16.98M | – |
| Q3 FY2021 | Sep 30, 2021 | $20.90M | – |
| Q2 FY2021 | Jun 30, 2021 | $5.57M | – |
| Q4 FY2020 | Dec 31, 2020 | $806.89K | – |
See a number that looks wrong?